Skip to main content
. Author manuscript; available in PMC: 2014 May 14.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Feb;15(2):242–248. doi: 10.1016/j.bbmt.2008.11.026

Figure 1.

Figure 1

Outcomes according to midtreatment PET result. (A) Intention-to-treat analysis of EFS of patients with positive midtreatment PET. (B) EFS of patients with positive midtreatment PET who received early transplantation. (C) EFS of patients with negative midtreatment PET. (D) Cumulative incidence of progression or relapse in all patients with positive midtreatment PET, according to PET scale score of 3+ versus 4+.